Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-08-30
2005-08-30
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S184000
Reexamination Certificate
active
06936608
ABSTRACT:
A class of 7-phenylimidazo[1,2-b][1,2,4]triazine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a —NH— linkage, being selective ligands for GABAAreceptors, in particular having good affinity for the α2 and/or α3 and/or α5 subunit thereof, are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.
REFERENCES:
patent: 3433194 (1969-03-01), Loev
patent: 6617326 (2003-09-01), Carling et al.
patent: 6696444 (2004-02-01), Carling et al.
patent: WO 00 78728 (2000-12-01), None
Scott et al. Prog. Med. Chem. 36: 169-200, 1999.
Bettati Michela
Blurton Peter
Carling William Robert
Chambers Mark Stuart
Hallett David James
Balasubramanian Venkataraman
Merck Sharp & Dohme Ltd.
Thies J. Eric
Winokur Melvin
LandOfFree
Imidazo-triazine derivatives as ligands for GABA receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazo-triazine derivatives as ligands for GABA receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazo-triazine derivatives as ligands for GABA receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3498814